L-dopa slows the progression of familial parkinsonism

Lancet. 1999 May 29;353(9167):1850-1. doi: 10.1016/S0140-6736(99)01398-7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antiparkinson Agents / therapeutic use*
  • Antiparkinson Agents / toxicity
  • Disease Progression
  • Humans
  • Levodopa / therapeutic use*
  • Levodopa / toxicity
  • Middle Aged
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / genetics*
  • Parkinson Disease / mortality
  • Survival Analysis

Substances

  • Antiparkinson Agents
  • Levodopa